[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2006, 32(2) 127-129 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
����ϸ��������������
Ƥ������
ϸ��������
��֢
���������������
����
�浤
PubMed
Article by JI Xi
Article by LUO Dan

����ϸ���ƶ�����������Ƥ��������Ե��о���չ

����, �浤

�Ͼ�ҽ�ƴ�ѧ��һ����ҽԺƤ���� 210029

ժҪ��

����ϸ���ƶ�����������һ��ǰ��֢����,���ɶ���ϸ������,������һ��ϸ������,����һ��Դ�ڴ���ļ���,��������Ϊ��Ƥ�ʼ��������ĸ��������ڼ������ž���ϸ���ƶ���������cDNA�ijɹ���¡����ṹ�IJ���,����ϸ���ƶ��������ӵ���������ѧ���Լ����ڶ��ּ����е���Ҫ����������Ϊ���������ӡ�����ϸ���ƶ��������ӵĹ��������ƾ���ϸ������,�ڶ���Ƥ�������ķ�����չ��,����ϸ���ƶ���������������Ҫ��ʼ�����ٽ����á�

�ؼ����� ����ϸ��������������   Ƥ������   ϸ��������   ��֢  

Macrophage Migration Inhibitory Factor and Its Relation with SMn Diseases

Department of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Department of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Abstract:

Macrophage migration inhibitory factor(MIF), produced by many kinds of cells, is a pro-inflammatory cytokine. Also, it is a pituitary-derived hormone and a negative feedback regulator of glucocorticoid activity. With the development of molecular cloning of MIF cDNA and elucidation of its structure, MIF is being increasingly recognized for its special biological properties and function in many dermatoses. Since MIF can inhibit the movement of macrophages, it plays an important role in the initiation and development of many dermatoses.

Keywords: Macrophage migration inhibitory factor   Skin diseases   Cytokines   Inflammation  
�ո����� 2005-05-31 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����:
���߼��:

�ο����ף�
[1] Roger T,David J,Glauser MP,et al.MIF regulates innate immune responses through modulation of Toil-like receptor 4.Nature,2001,414:920-924.
[2] Bernhagen J,Bacher M,Calandra T,et al.An essential role for macrophage migration inhibitory factor in the tuberculin delayedtype hypersensitivity reaction.J Exp Med,1996,183:277-282.
[3] Santos L,Hall P,Metz C,et al.Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis:interaction with glucocorticoids.Clin Exp Immunol,2001,123:309-314.
[4] Shimizu T,Abe R,Nishihira J,et al.Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice.Eur J Immunol,2003,33:1478-1487.
[5] Shimizu T,Abe R,Ohkawara A,et al.Ultraviolet B radiation upregulates the production of macrophage migration inhibitory factor(MIF) in human epidermal keratinocytes.J Invest Dermatol,1999,112:210.
[6] Watanabe H,Shimizu T,Nishihira J,et al.Ultraviolet A-induced production of matrix metalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts.J Biol Chem,2004,279:1676-1683.
[7] Wlaschek M,Wenk J,Brenneisen P,et al.Singlet oxygen is an early intermediate in cytokine-dependent ultraviolet-A induction of interstitial collagenase in human dermal fibroblasts in vitro.FEBS Lett,1997,413:239-242.
[8] Onodera S,Tanji H,Suzuki K,et al.High expression ofmacrophage migration inhibitory factor in the synovial tissues of rheumatoid joints.Cytokine,1999,11:163-167.
[9] Hoi AY,Morand EF,Leech M.Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus? Immunol Cell Biol,2003,81:367-373.
[10] Foote A,Briganti EM,Kipen Y,et al.Macrophage migration inhibitory factor in systemic lupus erythematosus.J Rheumatol,2004,31:268.
[11] Shimizu T,Abe R,Ohkawara A,et al.Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis.Biochem Biophys Res Commun,1997,240:173-178.
[12] Shimizu T,Abe R,Ohkawara A,et al.Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis.J Allergy Clin Immunol,1999,104 (3 Pt 1):659-664.
[13] Shimizu T,Nishihira J,Mizue Y,et al.High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis.J Invest Dermatol,2001,116:989-990.
[14] Takahashi N,Nishihira J,Sato Y,et al.Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth.Mol Med,1998,4:707-714.
[15] HudsonJD,ShoaibiMA,MaestroR,etal.Aproinflammatorycytokine inhibits p53 tumor suppressoractivity.JExpMed,1999,190:1375.
[16] Wrone-Smith T,Mitra RS,Thompson CB,et al.Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.Am J Pathol,1997,151:1321-1329.
[17] Shimizu T,Nishihira J,Watanabe H,et al.Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells.J Biol Chem,2004,279:13729-13737.
[18] Abe R,Shimizu T,Ohkawara A,et al.Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts.Biochim Biophys Acta,2000,1500:1-9.
[19] Ashcroft GS,Mills SJ,Lei K,et al.Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor.J Clin Invest,2003,111:1309-1318.
[20] Bini L,Magi B,Marzocchi B,et al.Protein expression profiles in human breast ductal carcinoma and histologically normal tissue.Electrophoresis,1997,18:2832-2841.
[21] Shimizu T,Abe R,Nakamura H,et al.High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis.Biochem Biophys Res Commun,1999,264:751-758.
[22] Chesney J,Metz C,Bacher M,et al.An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma.Mol Med,1999,5:181-191.
�������������
1������,�浤.����ϸ���ƶ��������������Ƥ��������Ե��о���չ[J]. ����Ƥ���Բ�ѧ��־, 2006,32(2): 127-

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־